Reversible modification of membrane interaction

Details Reversible modification of membrane interaction Reversible modification of membrane interaction

2006-03-28

2006-03-28

Campell, Bruce R. (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Synthesis of peptides

C530S300000, C530S335000, C530S336000, C530S337000, C530S345000

Reexamination Certificate

active

07019113

ABSTRACT:
An process for the reversible modification of membrane interaction of a compound is described. Modification of membrane interaction can be used to facilitate delivery of molecules to cells in vitro and in vivo. The described modifiers, which are used to reversibly inactivate the membrane active compounds, can also be utilized as cross-linkers or to reverse the charge of a molecule.

REFERENCES:
patent: 5985275 (1999-11-01), Neurath et al.
patent: 6590071 (2003-07-01), Shen et al.
patent: 6630351 (2003-10-01), Monahan et al.
patent: WO 00/75164 (2000-12-01), None
S Futaki, et al. J. Biol. Chem. (2001) 276, 5836-5840.
Blalller WA, Kuenzi BS, Lambert JM, Senter PD. New Heterobifunctional Protein Cross-Linking Reagent That Forms an Acid Labile Link. Biochemistry. 1985. 24:1517-1524.
Dixon HBF, Perham RN. Reversible Blocking of AAmino Groups with Citraconic Anhydride. Biochemical Journal. 1968. 109:312-313.
Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm. 2002. 245(1-2): 1-7.
Garman AJ, Kalindjian SB. The Preparation and Properties of Novel Reversible Polymer-Protein Conjugates. FEBS Letters. 1987. 223(2):364-365.
Greenwald, R.B., Conover, C.D., and Choe, Y.H. Polyethylene glycol) conjugated Drugs{circumflex over ())}{circumflex over (})}md Prodrugs: A Comprehensive Review. Critical Reviews in Therapeutic Drug Carrier Systems 2000. 17:101-161.
Kirby, AJ. and Lancaster, P.W. Structure and Efficiency in Intramolecular and Enzymic Catalysis. Catalysis of Amide Hydrolysis by the Carboxy-group of Substituted Malearmc Acids. J Chem Soc Perkin 1972.11:1206-1214.
Kratz F, Beyer U, Thomas-Schutte M. Drug-Polymer Conjugates Containing Acid-Cleavable Bonds. Critical Reviews in Therapeutic Drug Carrier Systems. 1999. 16(3):245-289.
Lee, H.J. and Pardridge, W.M. Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug Chem 2001. 12:995-999.
Lindgren, M., Hallbrink, M., Prochiantz, A{circumflex over ())}{circumflex over (})}. and Langel, U. Cell-penetrating peptides. Trends Pharmacol Sci 2000. 21:99-103.
Naganawa A, Ichikawa Y, Isobe MT. Synthetic Studies on Tautomycin Synthesis of 2,3-Disubstituted Maleic Anhydride Segment. Tetrahedron 1994. 50:8969.
Nieto MA, PalacianE. Effects of Temperature andpH on the Regeneration of the Amino Groups of Ovalbumin After Modification with Citraconic and Dimethylmaleic Anhydrides. Biochimica et Biophysica Acta. 1983. 749-204-210.
Reddy JA, Low PS. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. Journal of Controlled Release. 2000. 64:27-37.
Schwarze, S.R., Ho, A., Vocero-Akbani, A., and Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999. 285:1569-72.
Shah D, Shen WC. Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells. JPham Sci. 1996. 85(12):1306-1311.

Affiliated with

Also associated with

Rating

Reversible modification of membrane interaction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reversible modification of membrane interaction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reversible modification of membrane interaction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3551508